Park, Kwanjin <br/><br/>
Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.  [electronic resource] 

 -  The journal of sexual medicine  Nov 2006 
 - 996-1003 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1743-6095 
<br/><br/><label>Standard No.: </label>10.1111/j.1743-6109.2006.00327.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--administration & dosage<br/>Animals<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Impotence, Vasculogenic--drug therapy<br/>Intracellular Signaling Peptides and Proteins--administration & dosage<br/>Male<br/>Penile Erection--drug effects<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein Serine-Threonine Kinases--administration & dosage<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Vasodilator Agents--administration & dosage<br/>rho-Associated Kinases<br/>rhoA GTP-Binding Protein--drug effects